News Category: Regulatory news
The Health Products Regulatory Authority (HPRA) has welcomed the appointment of Dr David Murphy as Chair of the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP). Dr Murphy is the Veterinary Assessment Manager at the HPRA and has served as the Irish member of the CVMP for a number of years. Following his unanimous election at the recent CVMP meeting, Dr Murphy commences his role for a three year period with immediate effect.
Accepting his appointment, Dr Murphy highlighted the crucial animal and public health role of the CVMP and the vital part “it plays in ensuring the availability of good quality, safe and effective medicines for veterinary use”.
Dr Murphy, who joined the HPRA in 1999, has been involved in the activities of the CVMP for more than 15 years and recently acted as the Committee’s Vice-chair and Chair of the Strategic Planning Group. He has considerable expertise in the evaluation of veterinary medicines and an in-depth understanding of international regulatory affairs.
Dr Murphy holds a PhD from University of Glasgow and a Bachelor of Veterinary Medicine from University College Dublin.
About the Committee for Medicinal Products for Veterinary Use (CVMP)
The CVMP is responsible for preparing European Medicines Agency opinions on all questions concerning veterinary medicines. In particular, it plays a vital role in the marketing authorisation procedures of the European Union working to ensure that veterinary medicines that reach the marketplace have a positive benefit-risk balance in favour of the animal population they are intended for. The members of the CVMP, who are nominated by the European Union Member States in consultation with the Agency's Management Board, are chosen on the strength of their qualifications and expertise with regard to the evaluation of medicines.
Further information
- Weber Shandwick PR: (01) 679 8600
- Orla Molloy / Siobhan Molloy: 087 770 5108 / 086 817 5066